Developing an automated robotic factory for novel stem cell therapy production
Editorial discussing the need for new, advanced manufacturing platforms to be developed in order for advanced stem cell therapies, that is, cell and gene therapies, to achieve widespread clinical application, by Qasim A Rafiq, Karen Twomey, Michael Kulik et al. (from various organizations such as Fraunhofer Institute for Production Technology IPT in Germany and Cell & Gene Therapy Catapult in the UK).
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.